That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.
- 1 January 1993
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 52 (1), 74-80
- https://doi.org/10.1136/ard.52.1.74
Abstract
No abstract availableThis publication has 89 references indexed in Scilit:
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991
- Bone density screening for osteoporosisThe Lancet, 1990
- Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis.BMJ, 1990
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questionsAmerican Heart Journal, 1987
- A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving EstrogensNew England Journal of Medicine, 1986
- MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1981
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.BMJ, 1980